Health care companies by P/E ratio
Share price divided by the last twelve months' earnings per share: how many years of today's profit the price pays for. A company making a loss has none.
Charles River Laboratories International leads the 115 health care companies ranked by P/E ratio, at 361, ahead of Takeda Pharmaceutical (306) and Waters (193). Figures as of 19 Nov 2026, 17:41 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 115
- First
- Charles River Laboratories International361
- Median
- 30.2
- Combined market value
- SGD 11.56T
- Countries
- 14
- Not ranked
- 55no P/E ratio on file
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | P/E ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Charles River Laboratories InternationalCRL · Health Care | 361 | SGD 20.5B | SGD 428.43 | 0.44% down | 106% up | ||
| 2 | Takeda PharmaceuticalTAK · Health Care | 306 | SGD 88.4B | SGD 27.65 | 0.68% up | 51% up | ||
| 3 | WatersWAT · Health Care | 193 | SGD 117.4B | SGD 597.12 | 0.79% down | 23% up | ||
| 4 | Merck & CoMRK · Health Care | 135 | SGD 425.2B | SGD 172.49 | 3.06% down | 45% up | ||
| 5 | Ligand PharmaceuticalsLGND · Health Care | 117 | SGD 7.5B | SGD 376.21 | 2.47% down | 50% up | ||
| 6 | BiogenBIIB · Health Care | 107 | SGD 47.4B | SGD 320.46 | 1.29% down | 49% up | ||
| 7 | BillionToOneBLLN · Health Care | 99.5 | SGD 5.6B | SGD 118.24 | 0.02% up | 4% down | ||
| 8 | TG TherapeuticsTGTX · Health Care | 98.5 | SGD 12.9B | SGD 85.22 | 0.19% down | 117% up | ||
| 9 | SolventumSOLV · Health Care | 95.4 | SGD 18.6B | SGD 109.69 | 1.78% down | 9% up | ||
| 10 | Teva Pharmaceutical IndustriesTEVA · Health Care | 91.4 | SGD 59.2B | SGD 50.78 | 6.89% down | 74% up | ||
| 11 | MedlineMDLN · Health Care | 85.8 | SGD 64.1B | SGD 48.74 | 3.63% down | 4% down | ||
| 12 | PenumbraPEN · Health Care | 80.7 | SGD 16.3B | SGD 413.57 | 0.11% down | 15% up | ||
| 13 | TeleflexTFX · Health Care | 80.6 | SGD 8.4B | SGD 211.34 | 1.32% down | 58% up | ||
| 14 | ICONICLR · Health Care | 77.1 | SGD 18.7B | SGD 249.01 | 1.19% down | 23% up | ||
| 15 | LifeStance Health GroupLFST · Health Care | 74.0 | SGD 6.5B | SGD 17.21 | 3.23% down | 123% up | ||
| 16 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 72.1 | SGD 9.7B | SGD 122.87 | 0.11% up | 129% up | ||
| 17 | Jazz PharmaceuticalsJAZZ · Health Care | 71.2 | SGD 19.9B | SGD 310.63 | 2.92% down | 41% up | ||
| 18 | RevvityRVTY · Health Care | 68.5 | SGD 22.2B | SGD 199.10 | 1.15% up | 62% up | ||
| 19 | HeartflowHTFL · Health Care | 67.9 | SGD 5.2B | SGD 58.72 | 0.92% down | 66% up | ||
| 20 | Bio-TechneTECH · Health Care | 66.7 | SGD 14.8B | SGD 93.91 | 0.03% down | 24% up | ||
| 21 | Edwards LifesciencesEW · Health Care | 60.7 | SGD 77.5B | SGD 134.75 | 0.84% down | 25% up | ||
| 22 | IncyteINCY · Health Care | 59.4 | SGD 30.6B | SGD 150.31 | 1.19% down | 16% up | ||
| 23 | AlconALC · Health Care | 54.8 | SGD 46.6B | SGD 97.01 | 0.19% down | 0% up | ||
| 24 | Amneal PharmaceuticalsAMRX · Health Care | 53.3 | SGD 9.6B | SGD 27.55 | 2.49% down | 90% up | ||
| 25 | HaemoneticsHAE · Health Care | 53.0 | SGD 7B | SGD 154.67 | 2.52% down | 64% up | ||
| 26 | BeOne MedicinesONC · Health Care | 51.6 | SGD 59.3B | SGD 519.30 | 0.36% down | 16% up | ||
| 27 | Intuitive SurgicalISRG · Health Care | 50.2 | SGD 185.9B | SGD 536.21 | 1.36% down | 24% down | ||
| 28 | Corcept TherapeuticsCORT · Health Care | 49.0 | SGD 9.2B | SGD 84.22 | 3.79% down | 10% down | ||
| 29 | AbbVieABBV · Health Care | 48.6 | SGD 646.2B | SGD 365.58 | 1.02% down | 25% up | ||
| 30 | IDEXX LaboratoriesIDXX · Health Care | 46.6 | SGD 70.3B | SGD 892.30 | 1.07% down | 1% up | ||
| 31 | BrightSpring Health ServicesBTSG · Health Care | 45.7 | SGD 16.6B | SGD 83.27 | 5.65% down | 109% up | ||
| 32 | Royalty PharmaRPRX · Health Care | 44.4 | SGD 50.5B | SGD 87.76 | 1.03% down | 79% up | ||
| 33 | West Pharmaceutical ServicesWST · Health Care | 44.2 | SGD 35.4B | SGD 508.82 | 2.48% down | 57% up | ||
| 34 | GenmabGMAB · Health Care | 44.1 | SGD 41.1B | SGD 66.65 | 1.26% up | 70% up | ||
| 35 | Eli LillyLLY · Health Care | 44.0 | SGD 1.56T | SGD 1,751.78 | 1.90% down | 33% up | ||
| 36 | Krystal BiotechKRYS · Health Care | 43.0 | SGD 12.1B | SGD 408.71 | 0.37% up | 54% up | ||
| 37 | Becton, DickinsonBDX · Health Care | 42.0 | SGD 74.8B | SGD 274.45 | 1.64% down | 45% up | ||
| 38 | Dr. Reddy's LaboratoriesRDY · Health Care | 41.4 | SGD 16B | SGD 19.23 | 0.60% down | 8% up | ||
| 39 | Johnson & JohnsonJNJ · Health Care | 40.6 | SGD 831.5B | SGD 345.41 | 1.91% down | 34% up | ||
| 40 | PfizerPFE · Health Care | 39.5 | SGD 203.6B | SGD 35.73 | 1.41% down | 15% up | ||
| 41 | Abbott LaboratoriesABT · Health Care | 39.0 | SGD 233.5B | SGD 134.84 | 0.06% down | 16% down | ||
| 42 | DanaherDHR · Health Care | 37.8 | SGD 207.5B | SGD 295.01 | 0.06% down | 3% up | ||
| 43 | Mettler-Toledo InternationalMTD · Health Care | 37.1 | SGD 43.9B | SGD 2,208.88 | 1.54% down | 24% up | ||
| 44 | HumanaHUM · Health Care | 36.7 | SGD 58.4B | SGD 485.91 | 2.46% down | 73% up | ||
| 45 | Thermo Fisher ScientificTMO · Health Care | 36.7 | SGD 332.9B | SGD 898.36 | 0.42% up | 21% up | ||
| 46 | Medpace HoldingsMEDP · Health Care | 35.5 | SGD 23.1B | SGD 825.62 | 1.16% down | 10% up | ||
| 47 | IlluminaILMN · Health Care | 35.5 | SGD 40.2B | SGD 266.16 | 1.86% down | 76% up | ||
| 48 | Cardinal HealthCAH · Health Care | 35.3 | SGD 81.4B | SGD 352.28 | 1.99% down | 34% up | ||
| 49 | Agilent TechnologiesA · Health Care | 35.0 | SGD 64.7B | SGD 229.36 | 0.16% up | 22% up | ||
| 50 | HealthEquityHQY · Health Care | 34.6 | SGD 10.2B | SGD 123.92 | 1.39% down | 3% down | ||
| 51 | Vertex PharmaceuticalsVRTX · Health Care | 33.8 | SGD 172.1B | SGD 678.72 | 2.03% down | 27% up | ||
| 52 | StrykerSYK · Health Care | 33.5 | SGD 154.5B | SGD 405.86 | 1.21% down | 12% down | ||
| 53 | argenxARGX · Health Care | 32.7 | SGD 76.7B | SGD 1,219.25 | 0.31% up | 2% up | ||
| 54 | Merit Medical SystemsMMSI · Health Care | 31.8 | SGD 6.6B | SGD 109.60 | 1.23% down | 1% up | ||
| 55 | DexComDXCM · Health Care | 31.7 | SGD 38.8B | SGD 103.98 | 2.42% down | 41% up | ||
| 56 | IQVIA HoldingsIQV · Health Care | 30.8 | SGD 54B | SGD 327.37 | 1.68% down | 19% up | ||
| 57 | AvantorAVTR · Health Care | 30.3 | SGD 13.3B | SGD 19.56 | 1.43% down | 40% up | ||
| 58 | Labcorp HoldingsLH · Health Care | 30.2 | SGD 38.7B | SGD 476.24 | 0.54% down | 42% up | ||
| 59 | STERISSTE · Health Care | 30.2 | SGD 31.9B | SGD 328.86 | 1.89% down | 1% up | ||
| 60 | NovartisNVS · Health Care | 29.0 | SGD 370.2B | SGD 196.03 | 2.20% down | 25% up | ||
| 61 | McKessonMCK · Health Care | 27.2 | SGD 157.4B | SGD 1,363.12 | 2.66% down | 28% up | ||
| 62 | QiagenQGEN · Health Care | 26.8 | SGD 13.2B | SGD 63.99 | 0.01% down | 9% up | ||
| 63 | LivaNovaLIVN · Health Care | 26.6 | SGD 6.6B | SGD 120.09 | 1.63% down | 77% up | ||
| 64 | Protagonist TherapeuticsPTGX · Health Care | 26.4 | SGD 10.5B | SGD 161.53 | 1.63% down | 51% up | ||
| 65 | Ensign GroupENSG · Health Care | 26.4 | SGD 13.4B | SGD 229.33 | 2.95% down | 2% up | ||
| 66 | ChemedCHE · Health Care | 26.1 | SGD 9.1B | SGD 702.86 | 0.45% down | 27% up | ||
| 67 | Zimmer Biomet HoldingsZBH · Health Care | 26.0 | SGD 25.2B | SGD 133.00 | 0.31% down | 16% up | ||
| 68 | Quest DiagnosticsDGX · Health Care | 25.8 | SGD 36.8B | SGD 334.60 | 0.22% down | 38% up | ||
| 69 | Koninklijke PhilipsPHG · Health Care | 25.6 | SGD 37.1B | SGD 37.99 | 1.31% down | 12% up | ||
| 70 | AmgenAMGN · Health Care | 25.5 | SGD 307.4B | SGD 568.21 | 0.87% down | 32% up | ||
| 71 | Lantheus HoldingsLNTH · Health Care | 25.4 | SGD 8.6B | SGD 131.80 | 0.06% up | 90% up | ||
| 72 | AstraZenecaAZN · Health Care | 24.8 | SGD 351.7B | SGD 226.76 | 1.77% down | 1% up | ||
| 73 | MedtronicMDT · Health Care | 24.7 | SGD 166.3B | SGD 130.04 | 0.02% down | 1% up | ||
| 74 | Concentra Group Holdings ParentCON · Health Care | 24.4 | SGD 6.7B | SGD 53.27 | 1.59% down | 116% up | ||
| 75 | PACS GroupPACS · Health Care | 23.6 | SGD 8.5B | SGD 53.58 | 10.39% down | 77% up | ||
| 76 | Align TechnologyALGN · Health Care | 23.5 | SGD 14.7B | SGD 208.08 | 1.73% down | 23% up | ||
| 77 | Neurocrine BiosciencesNBIX · Health Care | 23.4 | SGD 20.6B | SGD 203.42 | 3.28% down | 17% up | ||
| 78 | Halozyme TherapeuticsHALO · Health Care | 23.1 | SGD 13.6B | SGD 119.52 | 3.39% down | 39% up | ||
| 79 | Henry ScheinHSIC · Health Care | 23.1 | SGD 12B | SGD 108.80 | 1.68% down | 20% up | ||
| 80 | Option Care HealthOPCH · Health Care | 22.9 | SGD 6.1B | SGD 40.82 | 0.32% down | 12% up | ||
| 81 | SanofiSNY · Health Care | 22.9 | SGD 142.7B | SGD 59.42 | 2.36% down | 4% down | ||
| 82 | MSA SafetyMSA · Health Care | 22.7 | SGD 8.8B | SGD 228.81 | 0.15% down | 16% up | ||
| 83 | InsuletPODD · Health Care | 22.4 | SGD 12.3B | SGD 177.20 | 1.97% down | 55% down | ||
| 84 | CenteneCNC · Health Care | 22.2 | SGD 41.4B | SGD 83.58 | 4.05% down | 94% up | ||
| 85 | ResMedRMD · Health Care | 21.7 | SGD 43.2B | SGD 307.01 | 2.01% down | 1% down | ||
| 86 | United TherapeuticsUTHR · Health Care | 21.3 | SGD 31.1B | SGD 729.61 | 2.14% down | 22% up | ||
| 87 | Encompass HealthEHC · Health Care | 20.9 | SGD 16.6B | SGD 168.75 | 3.15% down | 20% up | ||
| 88 | Cooper CompaniesCOO · Health Care | 20.7 | SGD 14.8B | SGD 77.83 | 0.79% down | 15% down | ||
| 89 | Regeneron PharmaceuticalsREGN · Health Care | 20.7 | SGD 125.1B | SGD 1,209.03 | 0.98% down | 28% up | ||
| 90 | Smith & NephewSNN · Health Care | 20.4 | SGD 16.2B | SGD 38.66 | 1.25% down | 5% down | ||
| 91 | ExelixisEXEL · Health Care | 19.8 | SGD 20.8B | SGD 85.18 | 3.40% down | 63% up | ||
| 92 | CencoraCOR · Health Care | 19.0 | SGD 83.9B | SGD 439.90 | 2.20% down | 4% down | ||
| 93 | UnitedHealth GroupUNH · Health Care | 18.8 | SGD 382B | SGD 426.36 | 5.64% down | 12% up | ||
| 94 | Boston ScientificBSX · Health Care | 18.3 | SGD 81.1B | SGD 55.97 | 0.68% down | 55% down | ||
| 95 | GE HealthCare TechnologiesGEHC · Health Care | 17.3 | SGD 47.9B | SGD 105.96 | 1.92% down | 12% up | ||
| 96 | Ascendis PharmaASND · Health Care | 17.2 | SGD 22.2B | SGD 337.95 | 3.19% down | 29% up | ||
| 97 | Globus MedicalGMED · Health Care | 17.1 | SGD 11.9B | SGD 89.81 | 1.40% down | 14% down | ||
| 98 | GSKGSK · Health Care | 16.7 | SGD 124.3B | SGD 62.01 | 1.15% down | 5% up | ||
| 99 | Elevance HealthELV · Health Care | 16.5 | SGD 108.7B | SGD 503.17 | 2.79% down | 28% up | ||
| 100 | HCA HealthcareHCA · Health Care | 15.3 | SGD 124.8B | SGD 597.45 | 2.88% down | 0% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 1.2914 SGD). 55 companies have no P/E ratio on file and are not ranked here.
Questions and answers
Which health care companies rank first by P/E ratio?
Charles River Laboratories International (361), Takeda Pharmaceutical (306) and Waters (193) are the top three of the 115 health care companies ranked by P/E ratio as of 19 Nov 2026, 17:41 UTC.
How many health care companies are in this ranking?
115 are ranked by P/E ratio. 55 more have no P/E ratio on file and are left out rather than ranked at zero.
What are these health care companies worth together?
The 115 health care companies ranked by P/E ratio have a combined market value of SGD 11.56T as of 19 Nov 2026, 17:41 UTC.
What does ranking by P/E ratio measure?
Share price divided by the last twelve months' earnings per share: how many years of today's profit the price pays for. A company making a loss has none.
Learn how this ranking works
All markets guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- PEG ratio: P/E adjusted for growth, and its limits
The PEG ratio is a stock's P/E divided by its expected yearly earnings growth in percent. A P/E of 20 with 10% expected growth gives a PEG of 2; with 20% growth, a PEG of 1. A PEG near 1 is the traditional rough mark of a fair price, but the growth figure is a forecast and often wrong.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care companies by P/E ratio”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=pe-ratio
Underlying data: Yahoo Finance; SEC EDGAR.